{"schema_version":"1.0.0","id":"se:pmod-2024-2","jurisdiction":"se","lang":"sv","judgment_class":"D","text_included":false,"text_note":"Full text is read from the official source. This record carries structured metadata and the text fingerprint.","word_count":11096,"cites":["C-121/17","C-650/17","C-493/12"],"sha256":"2948e8259f1064ff833a1d1bc15e4a55e7e9df674a3b5b7bc518f6cc7e0d7439","source_url":"https://rattspraxis.etjanst.domstol.se/api/v1/publiceringar/ec548d83-9951-480a-9c08-de1b2255abac","fetched_at":"2026-10-20T17:12:08.24+00:00","full_text_view":"https://legal.exploreworldai.com/api/public/v1/full-judgment/pmod-2024-2?view=full","risk_graph":"https://legal.exploreworldai.com/api/public/v1/risk?id=se:pmod-2024-2","relations_graph":"https://legal.exploreworldai.com/api/public/v1/relations?id=se:pmod-2024-2","agent":"https://legal.exploreworldai.com/api/public/v1/se-praxis/agent?id=se:pmod-2024-2","ref":"PMÖD 2024:2","court":"Patent- och marknadsöverdomstolen","decided":"2024-05-30","provisions":["Artikel 3 a i Europaparlamentets och rådets förordning (EG) nr 469/2009 av den 6 maj 2009 om tilläggsskydd för läkemedel"],"source":"NovaCopilot"}